ATE234865T1 - Neuartiges sythetisches peptil, diese enthaltende zusammensetzung und arznei-zusammensetzung und arznei gegen das atemnotsyndrom - Google Patents

Neuartiges sythetisches peptil, diese enthaltende zusammensetzung und arznei-zusammensetzung und arznei gegen das atemnotsyndrom

Info

Publication number
ATE234865T1
ATE234865T1 AT95902920T AT95902920T ATE234865T1 AT E234865 T1 ATE234865 T1 AT E234865T1 AT 95902920 T AT95902920 T AT 95902920T AT 95902920 T AT95902920 T AT 95902920T AT E234865 T1 ATE234865 T1 AT E234865T1
Authority
AT
Austria
Prior art keywords
peptide
peptil
sythetic
medicine
novel
Prior art date
Application number
AT95902920T
Other languages
English (en)
Inventor
Tsunetomo Takei
Eiji Ohtsubo
Hirosi Ohkawa
Original Assignee
Mitsubishi Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp
Application granted granted Critical
Publication of ATE234865T1 publication Critical patent/ATE234865T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
AT95902920T 1993-12-08 1994-12-07 Neuartiges sythetisches peptil, diese enthaltende zusammensetzung und arznei-zusammensetzung und arznei gegen das atemnotsyndrom ATE234865T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP30765793 1993-12-08
PCT/JP1994/002057 WO1995015980A1 (en) 1993-12-08 1994-12-07 Novel synthetic peptide, lung surfactant containing the same, and remedy for respiratory distress syndrome

Publications (1)

Publication Number Publication Date
ATE234865T1 true ATE234865T1 (de) 2003-04-15

Family

ID=17971685

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95902920T ATE234865T1 (de) 1993-12-08 1994-12-07 Neuartiges sythetisches peptil, diese enthaltende zusammensetzung und arznei-zusammensetzung und arznei gegen das atemnotsyndrom

Country Status (22)

Country Link
US (1) US5827825A (de)
EP (1) EP0733645B1 (de)
JP (1) JP3644035B2 (de)
KR (1) KR100342806B1 (de)
CN (1) CN1057099C (de)
AT (1) ATE234865T1 (de)
AU (1) AU682738B2 (de)
BG (1) BG62777B1 (de)
CA (1) CA2178345A1 (de)
CZ (1) CZ162396A3 (de)
DE (1) DE69432313T2 (de)
DK (1) DK0733645T3 (de)
ES (1) ES2189825T3 (de)
FI (1) FI962355A0 (de)
HU (1) HU215933B (de)
NO (1) NO962403D0 (de)
NZ (1) NZ277095A (de)
PL (1) PL180020B1 (de)
PT (1) PT733645E (de)
RO (1) RO118298B1 (de)
SK (1) SK71496A3 (de)
WO (1) WO1995015980A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2576895A (en) * 1994-12-07 1996-06-26 Tokyo Tanabe Company Limited Intermediate for producing surfactant peptide
AU2322097A (en) * 1996-03-27 1997-10-17 Ortho Pharmaceutical Corporation Lyophilized pulmonary surfactant peptide compositions
JPH11217397A (ja) * 1997-11-27 1999-08-10 Saburo Aimoto ペプチドチオールエステルの製造方法
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
BR9906091A (pt) * 1999-12-22 2002-06-04 Conselho Nacional Cnpq Usos de resina de troca aniÈnica (epm-7) como suporte sólido para a sìntese peptìdica e para cromatografia de afinidade
AU2002357168A1 (en) 2001-12-12 2003-07-09 Penn State Research Foundation Surfactant prevention of lung complications from cancer chemotherapy
ATE376556T1 (de) * 2003-12-31 2007-11-15 Hoffmann La Roche Verfahren zur peptidsynthese unter verwendung einer reduzierten menge an entschützungsmittel
US8029815B2 (en) * 2004-04-28 2011-10-04 Elford Howard L Methods for treating or preventing restenosis and other vascular proliferative disorders
US7638493B2 (en) * 2004-04-29 2009-12-29 Sannamu Lee Artificial pulmonary surfactant compositions and use of the same
KR100635541B1 (ko) * 2004-10-12 2006-10-18 경북대학교 산학협력단 신규한 염증성 질환의 예방 또는 치료용 약학적 조성물
US7464012B2 (en) * 2004-12-10 2008-12-09 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Simplified process simulator
US7582312B2 (en) * 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
SI1841458T1 (sl) 2005-01-06 2012-04-30 Discovery Lab Inc Zdravljenje s predpisanim odmerjanjem surfaktanta za zdravljenje ali preprečevanje bronhopulmonalne displazije
WO2007084136A2 (en) * 2006-01-23 2007-07-26 Ony, Inc. Treatment of acute respiratory distress syndrome
EP2063903A1 (de) * 2006-09-19 2009-06-03 Discovery Laboratories, Inc. Lungentensidformulierungen und verfahren zur förderung von schleimbeseitigung
EP2022798A1 (de) * 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetische Lungensurfactant-Peptide
WO2009123119A1 (ja) 2008-04-02 2009-10-08 国立大学法人徳島大学 合成ペプチドを含有する抗原薬物ビークルとこれを用いる粘膜ワクチン
WO2013188016A2 (en) 2012-05-04 2013-12-19 Discovery Laboratories, Inc. Surfactant therapy for exposure to ionizing radiation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988003170A1 (en) * 1986-10-24 1988-05-05 Whitsett Jeffrey A Pulmonary hydrophobic surfactant-associated proteins
JPH01501282A (ja) * 1986-12-08 1989-05-11 ホイツトセツト，ジエフリー　エイ． 肺胞疎水性界面活性物質関連タンパク質
ATE163013T1 (de) * 1987-11-04 1998-02-15 Byk Gulden Lomberg Chem Fab Alveolare oberflächenaktive proteine
US5260273A (en) * 1988-01-06 1993-11-09 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
SE8803713D0 (sv) * 1988-10-18 1988-10-18 Kabigen Ab Biologically active lipoprotein and its use
JPH05294996A (ja) * 1992-04-17 1993-11-09 Tokyo Tanabe Co Ltd 合成ペプチド、それを含有する肺サーファクタント及び呼吸窮迫症候群治療剤

Also Published As

Publication number Publication date
US5827825A (en) 1998-10-27
PL180020B1 (en) 2000-12-29
NZ277095A (en) 1997-09-22
JP3644035B2 (ja) 2005-04-27
WO1995015980A1 (en) 1995-06-15
NO962403L (no) 1996-06-07
CZ162396A3 (en) 1996-10-16
FI962355L (fi) 1996-06-06
KR960706507A (ko) 1996-12-09
EP0733645A4 (de) 1998-12-09
BG62777B1 (bg) 2000-07-31
HU9601563D0 (en) 1996-08-28
CN1057099C (zh) 2000-10-04
PT733645E (pt) 2003-07-31
NO962403D0 (no) 1996-06-07
DE69432313D1 (de) 2003-04-24
CN1136813A (zh) 1996-11-27
SK71496A3 (en) 1996-11-06
FI962355A7 (fi) 1996-06-06
ES2189825T3 (es) 2003-07-16
DE69432313T2 (de) 2003-10-16
KR100342806B1 (ko) 2002-11-29
RO118298B1 (ro) 2003-04-30
PL314872A1 (en) 1996-09-30
CA2178345A1 (en) 1995-06-15
FI962355A0 (fi) 1996-06-06
AU682738B2 (en) 1997-10-16
HU215933B (hu) 1999-03-29
BG100554A (bg) 1996-12-31
EP0733645A1 (de) 1996-09-25
HUT74880A (en) 1997-02-28
EP0733645B1 (de) 2003-03-19
AU1199295A (en) 1995-06-27
DK0733645T3 (da) 2003-07-14

Similar Documents

Publication Publication Date Title
ATE234865T1 (de) Neuartiges sythetisches peptil, diese enthaltende zusammensetzung und arznei-zusammensetzung und arznei gegen das atemnotsyndrom
NO893166L (no) Makrocykliske forbindelser.
KR960701049A (ko) 헤테로사이클릭 화합물, 이의 제조방법 및 이의 용도(Heterocyclic compounds and their preparation and use)
DE69128145D1 (de) 1,2,5,6-tetrahydro-1-methylpyridine, ihre herstellung und anwendung
DK193887D0 (da) Fysiologisk aktivt peptid
IT1212900B (it) Uso terapeutico della fosfatidilserina in malattie del sistema nervoso centrale senza effetti sulla coagulazione sanguigna
CA2189947A1 (en) Use of von willebrand factor and pharmaceutical formulation
FI903280A0 (fi) Menetelmä terapeuttisesti käyttökelpoisen 1-/4,5-dihydroksi-N2-(10,12-dimetyyli-1-oksotetradekyyli)ornitiini/-5-(3-hydroksiglutamiini)-6-(3-hydroksiproliini)ekinokandiini B:n valmistamiseksi
DE69005697D1 (de) Verfahren zur Herstellung von 1,1-Dichlor-1-fluorethan.
HUP0002533A2 (hu) Asztmaellenes gyógyszerhatóanyagok új kombinációja
NO924578D0 (no) Ny taurinbasert farmasoeytisk blanding for administrering ved inhalasjon
AU629445B2 (en) Improvements in or relating to topical compositions containing 1 alpha 25-dihydroxycholecalciferol
IL95892A0 (en) Aroyl-ureas,their preparation and pharmaceutical compositions containing them
GB1159000A (en) 2,2-Dichloro-1,1,3,3-Tetrafluoropropane
DK0911038T3 (da) Vandfri sammensætning omfattende lactulose
DK43891D0 (da) Pentapeptid og fremgangsmaade til fremstilling deraf
ES2074714T3 (es) Compuestos aciclicos o azabiciclicos, su preparacion y uso.
ATE73743T1 (de) Agglomeriertes produkt, seine herstellung und seine anwendung.
UA19456C2 (uk) СПОСІБ ВИДІЛЕHHЯ beta-МЕТИЛHАФТАЛІHУ ІЗ СИРОВИHИ З ПІДВИЩЕHИМ ВМІСТОМ HАСИЧЕHИХ ВУГЛЕВОДHІВ

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0733645

Country of ref document: EP

REN Ceased due to non-payment of the annual fee